# Opus Genetics, Inc.: insider transactions

IRD · Nasdaq · CIK 1228627 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ird.md) · [Financials](/companies/ird/financials.md) · [Filings](/companies/ird/filings.md) · [Insiders](/companies/ird/insiders.md)

## All transactions: 5

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-23 | [Schachle Joseph K](/insiders/1145914.md) | Chief Operating Officer, Officer | Sale (S) | 4,767 | $3.565 | $17.0k | [Form 4](/filings/0001140361-26-040908.md) |
| 2026-10-23 | [Yerxa Benjamin R](/insiders/1145910.md) | President, Director, Officer | Sale (S) | 25,520 | $3.5317 | $90.1k | [Form 4](/filings/0001140361-26-040906.md) |
| 2026-10-23 | [Yerxa Benjamin R](/insiders/1145910.md) | President, Director, Officer | Sale (S) | 7,669 | $3.5514 | $27.2k | [Form 4](/filings/0001140361-26-040906.md) |
| 2026-10-23 | [Gagnon Robert E.](/insiders/1504983.md) | Chief Financial Officer, Officer | Sale (S) | 14,000 | $3.5464 | $49.6k | [Form 4](/filings/0001140361-26-040896.md) |
| 2026-10-23 | [Magrath George](/insiders/1999390.md) | Chief Executive Officer, Director, Officer | Sale (S) | 9,591 | $3.585 | $34.4k | [Form 4](/filings/0001140361-26-040893.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 27, 2026, 16:48 ET. No prices; not investment advice.